Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule

Core Insights - Maravai LifeSciences, Inc. is actively participating in several investor conferences in August and September 2024, highlighting its engagement with the investment community [1][2][3]. Conference Participation - On August 14, 2024, CEO Trey Martin will discuss the Critical Components of the Genomic Medicine Supply Chain at the UBS Genomic Medicine Conference in Dana Point, CA, at 11:00 a.m. PDT [2]. - On September 4, 2024, both CEO Trey Martin and CFO Kevin Herde will engage in a fireside chat at the Wells Fargo Healthcare Conference in Boston, MA, at 6:30 a.m. PDT [2]. - On September 5, 2024, Trey Martin and Kevin Herde will participate in another fireside chat at the Morgan Stanley Healthcare Conference in New York, NY, at 1:50 p.m. PDT [3]. Webcast Availability - Live webcasts of each presentation will be accessible on the Maravai LifeSciences Investor Relations website, with archived versions available post-event [4]. Company Overview - Maravai LifeSciences is a leading provider of life science reagents and services, focusing on drug therapies, diagnostics, and novel vaccines, and supports research on human diseases [5]. - The company specializes in nucleic acid synthesis and biologics safety testing, serving many top biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies globally [5].